Publicaciones
El conocimiento generado en IrsiCaixa se comparte con la comunidad científica a través de la publicación de artículos en revistas científicas de alto impacto.
SARS-CoV-2 infection elicits a rapid neutralizing antibody response that correlates with disease severity.
Previous SARS-CoV-2 Infection Increases B.1.1.7 Cross-Neutralization by Vaccinated Individuals.
Monitoring Natural SARS-CoV-2 Infection in Lions ( Panthera leo) at the Barcelona Zoo: Viral Dynamics and Host Responses
Stable neutralizing antibody levels 6 months after mild and severe COVID-19 episodes
Protection against reinfection with D614- or G614-SARS-CoV-2 isolates in golden Syrian hamster.
Mouthwashes with CPC Reduce the Infectivity of SARS-CoV-2 Variants In Vitro.
First Detection of SARS-CoV-2 Delta (B.1.617.2) Variant of Concern in a Dog with Clinical Signs in Spain.
SARS-CoV-2 Cellular Infection and Therapeutic Opportunities: Lessons Learned from Ebola Virus.
Plitidepsin has a positive therapeutic index in adult patients with COVID-19 requiring hospitalization.
SARS-CoV-2 interaction with Siglec-1 mediates trans-infection by dendritic cells.